
Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …

As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm …

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …

FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …

MSD has unveiled new Phase 3 data for its blockbuster anti-PD-1 immunotherapy Keytruda (pembrolizumab), showing that the drug succeeded in …

An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …

DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …

California-based pharma firm, Aimunne Therapeutics has been notified that due to the government shutdown, the US Food and Drug Administration …

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …

Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …

Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in …

Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …

Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …

Congressman Elijah Cummings has launched an investigation into pharmaceutical pricing practices.The representative for Maryland’s 7th congressional district, on Monday requested …

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …

Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …

The British Government has come under fire over the appointment of former Tory MP, Nicola Blackwood, as a junior minister …

2018 was a strong year for European approvals according to the EMA; the regulator has recently released its Human medicines …